{"count": 6, "results": [{"_id": "35685961", "pmid": 35685961, "pmcid": "PMC9085158", "title": "METNET: a phase II trial of metformin in patients with well-differentiated neuroendocrine tumours", "journal": "Ecancermedicalscience", "authors": ["Glasberg J", "Talans A", "Giollo TR", "Recchimuzzi DZ", "Neto JEB", "Lopez RVM", "Hoff PMG", "Riechelmann RP"], "date": "2022-03-31T00:00:00Z", "doi": "10.3332/ecancer.2022.1369", "meta_date_publication": "2022", "meta_volume": "16", "meta_issue": "", "meta_pages": "1369", "score": 50254.227, "text_hl": "To evaluate the efficacy and safety of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ monotherapy in @SPECIES_9606 @@@patients@@@ with advanced/metastatic well-differentiated @DISEASE_Neoplasms @DISEASE_MESH:D009369 @@@NET@@@ (@<m>DISEASE_Leukemia_Lymphocytic_Chronic_B_Cell</m> @DISEASE_MESH:D015451 @@@WD-NET@@@) of gastroenteropancreatic (GEP) or pulmonary origin.", "citations": {"NLM": "Glasberg J, Talans A, Giollo TR, Recchimuzzi DZ, Neto JEB, Lopez RVM, Hoff PMG, Riechelmann RP. METNET: a phase II trial of metformin in patients with well-differentiated neuroendocrine tumours Ecancermedicalscience. 2022;16():1369. PMID: 35685961", "BibTeX": "@article{35685961, title={METNET: a phase II trial of metformin in patients with well-differentiated neuroendocrine tumours}, author={Glasberg J and Talans A and Giollo TR and Recchimuzzi DZ and Neto JEB and Lopez RVM and Hoff PMG and Riechelmann RP}, journal={Ecancermedicalscience}, volume={16}, pages={1369}}"}}, {"_id": "35496297", "pmid": 35496297, "pmcid": "PMC9043685", "title": "Metformin and Thymoquinone Synergistically Inhibit Proliferation of Imatinib-Resistant Human Leukemic Cells", "journal": "Front Pharmacol", "authors": ["Glamoclija U", "Mahmutovic L", "Bilajac E", "Soljic V", "Vukojevic K", "Suljagic M"], "date": "2022-04-13T00:00:00Z", "doi": "10.3389/fphar.2022.867133", "meta_date_publication": "2022", "meta_volume": "13", "meta_issue": "", "meta_pages": "867133", "score": 50252.902, "text_hl": "Combinatorial therapy with @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ and @CHEMICAL_Dasatinib @CHEMICAL_MESH:D000069439 @@@dasatinib@@@ in @<m>DISEASE_Leukemia_Lymphocytic_Chronic_B_Cell</m> @DISEASE_MESH:D015451 @@@chronic lymphocytic leukemia@@@ (@<m>DISEASE_Leukemia_Lymphocytic_Chronic_B_Cell</m> @DISEASE_MESH:D015451 @@@CLL@@@) is one of the promising approaches. ", "citations": {"NLM": "Glamoclija U, Mahmutovic L, Bilajac E, Soljic V, Vukojevic K, Suljagic M. Metformin and Thymoquinone Synergistically Inhibit Proliferation of Imatinib-Resistant Human Leukemic Cells Front Pharmacol. 2022;13():867133. PMID: 35496297", "BibTeX": "@article{35496297, title={Metformin and Thymoquinone Synergistically Inhibit Proliferation of Imatinib-Resistant Human Leukemic Cells}, author={Glamoclija U and Mahmutovic L and Bilajac E and Soljic V and Vukojevic K and Suljagic M}, journal={Front Pharmacol}, volume={13}, pages={867133}}"}}, {"_id": "26265439", "pmid": 26265439, "pmcid": "PMC4673187", "title": "Metformin inhibits cell cycle progression of B-cell chronic lymphocytic leukemia cells", "journal": "Oncotarget", "authors": ["Bruno S", "Ledda B", "Tenca C", "Ravera S", "Orengo AM", "Mazzarello AN", "Pesenti E", "Casciaro S", "Racchi O", "Ghiotto F", "Marini C", "Sambuceti G", "DeCensi A", "Fais F"], "date": "2015-09-08T00:00:00Z", "doi": "10.18632/oncotarget.4168", "meta_date_publication": "2015 Sep 8", "meta_volume": "6", "meta_issue": "26", "meta_pages": "22624-40", "score": 50064.324, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ inhibits cell cycle progression of B-cell @<m>DISEASE_Leukemia_Lymphocytic_Chronic_B_Cell</m> @DISEASE_MESH:D015451 @@@chronic lymphocytic leukemia@@@ cells", "citations": {"NLM": "Bruno S, Ledda B, Tenca C, Ravera S, Orengo AM, Mazzarello AN, Pesenti E, Casciaro S, Racchi O, Ghiotto F, Marini C, Sambuceti G, DeCensi A, Fais F. Metformin inhibits cell cycle progression of B-cell chronic lymphocytic leukemia cells Oncotarget. 2015 Sep 8;6(26):22624-40. PMID: 26265439", "BibTeX": "@article{26265439, title={Metformin inhibits cell cycle progression of B-cell chronic lymphocytic leukemia cells}, author={Bruno S and Ledda B and Tenca C and Ravera S and Orengo AM and Mazzarello AN and Pesenti E and Casciaro S and Racchi O and Ghiotto F and Marini C and Sambuceti G and DeCensi A and Fais F}, journal={Oncotarget}, volume={6}, number={26}, pages={22624-40}}"}}, {"_id": "24828872", "pmid": 24828872, "title": "Investigating and targeting chronic lymphocytic leukemia metabolism with the human immunodeficiency virus protease inhibitor ritonavir and metformin.", "journal": "Leuk Lymphoma", "authors": ["Adekola KU", "Dalva Aydemir S", "Ma S", "Zhou Z", "Rosen ST", "Shanmugam M"], "date": "2015-02-01T00:00:00Z", "doi": "10.3109/10428194.2014.922180", "meta_date_publication": "2015 Feb", "meta_volume": "56", "meta_issue": "2", "meta_pages": "450-9", "score": 50058.504, "text_hl": "Investigating and targeting @<m>DISEASE_Leukemia_Lymphocytic_Chronic_B_Cell</m> @DISEASE_MESH:D015451 @@@chronic lymphocytic leukemia@@@ metabolism with the @SPECIES_12721 @@@human immunodeficiency virus@@@ protease inhibitor @CHEMICAL_Ritonavir @CHEMICAL_MESH:D019438 @@@ritonavir@@@ and @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@.", "citations": {"NLM": "Adekola KU, Dalva Aydemir S, Ma S, Zhou Z, Rosen ST, Shanmugam M. Investigating and targeting chronic lymphocytic leukemia metabolism with the human immunodeficiency virus protease inhibitor ritonavir and metformin. Leuk Lymphoma. 2015 Feb;56(2):450-9. PMID: 24828872", "BibTeX": "@article{24828872, title={Investigating and targeting chronic lymphocytic leukemia metabolism with the human immunodeficiency virus protease inhibitor ritonavir and metformin.}, author={Adekola KU and Dalva Aydemir S and Ma S and Zhou Z and Rosen ST and Shanmugam M}, journal={Leuk Lymphoma}, volume={56}, number={2}, pages={450-9}}"}}, {"_id": "26959881", "pmid": 26959881, "pmcid": "PMC4951344", "title": "Metformin combined with sodium dichloroacetate promotes B leukemic cell death by suppressing anti-apoptotic protein Mcl-1", "journal": "Oncotarget", "authors": ["Voltan R", "Rimondi E", "Melloni E", "Gilli P", "Bertolasi V", "Casciano F", "Rigolin GM", "Zauli G", "Secchiero P"], "date": "2016-04-05T00:00:00Z", "doi": "10.18632/oncotarget.7879", "meta_date_publication": "2016 Apr 5", "meta_volume": "7", "meta_issue": "14", "meta_pages": "18965-77", "score": 50053.69, "text_hl": "...@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ promotes cytotoxicity in B @DISEASE_Leukemia @DISEASE_MESH:D007938 @@@leukemic@@@ cell lines and in primary @<m>DISEASE_Leukemia_Lymphocytic_Chronic_B_Cell</m> @DISEASE_MESH:D015451 @@@B-CLL@@@ cells", "citations": {"NLM": "Voltan R, Rimondi E, Melloni E, Gilli P, Bertolasi V, Casciano F, Rigolin GM, Zauli G, Secchiero P. Metformin combined with sodium dichloroacetate promotes B leukemic cell death by suppressing anti-apoptotic protein Mcl-1 Oncotarget. 2016 Apr 5;7(14):18965-77. PMID: 26959881", "BibTeX": "@article{26959881, title={Metformin combined with sodium dichloroacetate promotes B leukemic cell death by suppressing anti-apoptotic protein Mcl-1}, author={Voltan R and Rimondi E and Melloni E and Gilli P and Bertolasi V and Casciano F and Rigolin GM and Zauli G and Secchiero P}, journal={Oncotarget}, volume={7}, number={14}, pages={18965-77}}"}}, {"_id": "25847249", "pmid": 25847249, "title": "In Silico Modeling-based Identification of Glucose Transporter 4 (GLUT4)-selective Inhibitors for Cancer Therapy.", "journal": "J Biol Chem", "authors": ["Mishra RK", "Wei C", "Hresko RC", "Bajpai R", "Heitmeier M", "Matulis SM", "Nooka AK", "Rosen ST", "Hruz PW", "Schiltz GE", "Shanmugam M"], "date": "2015-06-05T00:00:00Z", "doi": "10.1074/jbc.M114.628826", "meta_date_publication": "2015 Jun 5", "meta_volume": "290", "meta_issue": "23", "meta_pages": "14441-53", "score": 50029.223, "text_hl": "@GENE_SLC2A4 @GENE_6517 @@@GLUT4@@@ inhibition also caused sensitization to @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ in @DISEASE_Multiple_Myeloma @DISEASE_MESH:D009101 @@@multiple myeloma@@@ and @<m>DISEASE_Leukemia_Lymphocytic_Chronic_B_Cell</m> @DISEASE_MESH:D015451 @@@chronic lymphocytic leukemia@@@ and a number of solid @DISEASE_Neoplasms @DISEASE_MESH:D009369 @@@tumors@@@ suggesting the broader therapeutic utility of targeting @GENE_SLC2A4 @GENE_6517 @@@GLUT4@@@. ", "citations": {"NLM": "Mishra RK, Wei C, Hresko RC, Bajpai R, Heitmeier M, Matulis SM, Nooka AK, Rosen ST, Hruz PW, Schiltz GE, Shanmugam M. In Silico Modeling-based Identification of Glucose Transporter 4 (GLUT4)-selective Inhibitors for Cancer Therapy. J Biol Chem. 2015 Jun 5;290(23):14441-53. PMID: 25847249", "BibTeX": "@article{25847249, title={In Silico Modeling-based Identification of Glucose Transporter 4 (GLUT4)-selective Inhibitors for Cancer Therapy.}, author={Mishra RK and Wei C and Hresko RC and Bajpai R and Heitmeier M and Matulis SM and Nooka AK and Rosen ST and Hruz PW and Schiltz GE and Shanmugam M}, journal={J Biol Chem}, volume={290}, number={23}, pages={14441-53}}"}}]}